447 related articles for article (PubMed ID: 9625726)
21. O6-methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung.
Peterson LA; Hecht SS
Cancer Res; 1991 Oct; 51(20):5557-64. PubMed ID: 1913675
[TBL] [Abstract][Full Text] [Related]
22. Carcinogenicity and metabolic activation of tobacco-specific nitrosamines: current status and future prospects.
Hecht SS; Castonguay A; Chung FL; Hoffmann D
IARC Sci Publ; 1984; (57):763-78. PubMed ID: 6398307
[TBL] [Abstract][Full Text] [Related]
23. Effect of vitamin E and beta-carotene on DNA strand breakage induced by tobacco-specific nitrosamines and stimulated human phagocytes.
Weitberg AB; Corvese D
J Exp Clin Cancer Res; 1997 Mar; 16(1):11-4. PubMed ID: 9148854
[TBL] [Abstract][Full Text] [Related]
24. Identification of O2-substituted pyrimidine adducts formed in reactions of 4-(acetoxymethylnitrosamino)- 1-(3-pyridyl)-1-butanone and 4-(acetoxymethylnitros- amino)-1-(3-pyridyl)-1-butanol with DNA.
Hecht SS; Villalta PW; Sturla SJ; Cheng G; Yu N; Upadhyaya P; Wang M
Chem Res Toxicol; 2004 May; 17(5):588-97. PubMed ID: 15144215
[TBL] [Abstract][Full Text] [Related]
25. Induction of COX expression by a tobacco carcinogen: implication in lung cancer chemoprevention.
Rioux N; Castonguay A
Inflamm Res; 1999 Dec; 48 Suppl 2():S136-7. PubMed ID: 10667852
[No Abstract] [Full Text] [Related]
26. Evidence supporting the role of DNA pyridyloxobutylation in rat nasal carcinogenesis by tobacco-specific nitrosamines.
Trushin N; Rivenson A; Hecht SS
Cancer Res; 1994 Mar; 54(5):1205-11. PubMed ID: 8118807
[TBL] [Abstract][Full Text] [Related]
27. N-nitroso compounds and tobacco-induced cancers in man.
Hecht SS; Hoffmann D
IARC Sci Publ; 1991; (105):54-61. PubMed ID: 1855913
[TBL] [Abstract][Full Text] [Related]
28. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
Hu W; Feng Z; Tang MS
Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
[TBL] [Abstract][Full Text] [Related]
29. Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine in Syrian golden hamsters.
Hoffmann D; Castonguay A; Rivenson A; Hecht SS
Cancer Res; 1981 Jun; 41(6):2386-93. PubMed ID: 7237437
[TBL] [Abstract][Full Text] [Related]
30. Effect of ascorbate on amine-nitrite carcinogenicity.
Fong YY; Chan WC
IARC Sci Publ (1971); 1976; (14):461-4. PubMed ID: 1002210
[No Abstract] [Full Text] [Related]
31. The development of scientific consultants: how the tobacco industry creates controversy on the carcinogenicity of tobacco-specific nitrosamines.
Kyriss T; Schneider NK
Tob Control; 2013 May; 22(3):e3. PubMed ID: 22940678
[TBL] [Abstract][Full Text] [Related]
32. Organ specific genotoxicity and carcinogenicity.
Pool BL; Schmezer P; Tompa A; Brendler SY
Prog Clin Biol Res; 1990; 340D():33-41. PubMed ID: 2371304
[TBL] [Abstract][Full Text] [Related]
33. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.
De Flora S; Balansky RM; D'Agostini F; Izzotti A; Camoirano A; Bennicelli C; Zhang Z; Wang Y; Lubet RA; You M
Cancer Res; 2003 Feb; 63(4):793-800. PubMed ID: 12591728
[TBL] [Abstract][Full Text] [Related]
34. Tobacco-specific nitrosamine-hemoglobin adducts.
Hecht SS; Carmella SG; Murphy SE
Methods Enzymol; 1994; 231():657-67. PubMed ID: 8041285
[No Abstract] [Full Text] [Related]
35. Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions.
Hoffmann D; Hecht SS
Cancer Res; 1985 Mar; 45(3):935-44. PubMed ID: 3882226
[No Abstract] [Full Text] [Related]
36. Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines.
Trejo-Martin A; Bercu JP; Thresher A; Tennant RE; Thomas RF; Cross K; Czich A; Waese K; Nicolette JJ; Murray J; Sonders P; Kondratiuk A; Cheung JR; Thomas D; Lynch A; Harvey J; Glowienke S; Custer L; Escobar PA
Regul Toxicol Pharmacol; 2022 Nov; 135():105247. PubMed ID: 35998738
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of nitrosamine bioactivation and carcinogenesis.
Yang CS; Smith TJ
Adv Exp Med Biol; 1996; 387():385-94. PubMed ID: 8794233
[No Abstract] [Full Text] [Related]
38. The molecular perspective: nicotine and nitrosamines.
Goodsell DS
Stem Cells; 2004; 22(4):645-6. PubMed ID: 15277710
[No Abstract] [Full Text] [Related]
39. Carcinogenicity of some aromatic amines and related compounds.
IARC Monographs Vol 127 group
Lancet Oncol; 2020 Aug; 21(8):1017-1018. PubMed ID: 32593317
[No Abstract] [Full Text] [Related]
40. Utilisation of parametric methods to improve percentile-based estimates for the carcinogenic potency of nitrosamines.
Thomas R; Thresher A; Ponting DJ
Regul Toxicol Pharmacol; 2021 Apr; 121():104875. PubMed ID: 33556416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
